Notable Wednesday Option Activity: VRT, CDTX, LMND

Cidara Therapeutics (CDTX) and Lemonade (LMND) are experiencing notable options trading activity, with volumes representing 85.9% and 80.1% of their respective average daily share trading volumes. This surge is particularly concentrated in specific out-of-the-money call options—the $65 strike for CDTX expiring November 2025 and the $60 strike for LMND expiring August 2025—indicating significant speculative interest or bullish sentiment in these names.

Analysis

Significant options market activity has been observed in Cidara Therapeutics (CDTX) and Lemonade (LMND), with total options volumes reaching 85.9% and 80.1% of their respective average daily share volumes. This activity is not broad-based but is highly concentrated in specific long-dated, out-of-the-money call options. For CDTX, 1,006 contracts of the November 2025 $65 strike call were traded, while LMND saw 3,135 contracts of the August 2025 $60 strike call change hands. Such concentrated buying in far-dated, far out-of-the-money calls points towards significant speculative interest, potentially from investors positioning for a substantial long-term turnaround or a major positive catalyst in these companies, rather than near-term price movements.

Key Decisions for Investors

• Investors should investigate potential fundamental catalysts or upcoming news for CDTX and LMND that could underpin the highly speculative, long-term bullish bets observed in the options market.
• Monitoring the open interest and subsequent trading volume in the specific November 2025 $65 calls for CDTX and the August 2025 $60 calls for LMND can serve as a key indicator of the conviction behind these positions.
• While the activity suggests bullish sentiment, it could also be part of a complex hedging strategy, so it is prudent to treat this signal with caution and not overweight positions based solely on this options flow.